Bill Ericson

Bill Ericson is a Founding Partner at Wildcat Venture Partners and a General Partner at Mohr Davidow Ventures where his focus is on the big data revolution that is driving the commercial, consumer media and health care worlds. Bill has been working with startups for his entire career, and partners with strong minded entrepreneurs who want to attack big markets and want help that can accelerate their vision. Over the past decade, Bill has led investments in transformative technology companies including now public Rocket Fuel (NASDAQ: FUEL), Pacific Biosciences (NYSE: PACB), and Adamas Pharmaceuticals (NASDAQ: ADMS), and successfully acquired companies Ticketfly (acquired by NASDAQ:P), Verinata (acquired by NASDAQ:ILMN), OpenDNS (acquired by NASDAQ:CSCO), Sabrix (acquired by NYSE:TRI), Rosetta Inpharmatics (NASDAQ: RSTA, acquired by NYSE:MRK), Sequenta (acquired by Adaptive Biotechnologies) and Parallele (acquired by NASDAQ:AFFX). Bill received his B.S.F.S. from Georgetown University of Foreign Service and J.D. from Northwestern University School of Law.